Display options

You can modify the default view of progscrape using query parameters.

Feedback? Email [email protected]

progscrape https://progscrape.com/
Trending tags: ai  github.com  rust  vibecoding  iran  linux  show  game  apple  theguardian.com  health  i.redd.it  arstechnica.com  openai  neuroscience  psypost.org  tomshardware.com  psychology  google  microsoft 
Loading...

Tag trends are in beta. Feedback? Thoughts? Email me at [email protected]

Scientists turn pig semen extract into eye drops that kill cancer in mice

4 days ago fiercebiotech.com cancer

Genetically modified parasite successfully delivers drugs across the blood-brain barrier in mice, a potential new avenue for safely and effectively getting drugs to the human brain to treat neurological diseases

20 months ago fiercebiotech.com brain neuroscience

With seventh person seemingly cured of HIV, signs of hope for a broader cure

20 months ago fiercebiotech.com

Beyond headlines of transmitted Alzheimer's, scientists see case for prions

24 months ago fiercebiotech.com

Lilly makes waves, says gene therapy restores hearing for child with genetic hearing loss

2 years ago fiercebiotech.com genetics

Scientists use probiotic bacteria to enhance T cell cancer therapy

2 years ago fiercebiotech.com cancer

Lilly's 10-year bet on treating Alzheimer's before symptoms start ends in failure

3 years ago fiercebiotech.com

Russian invasion of Ukraine could affect more than 200 clinical trials across biotech and pharma

4 years ago fiercebiotech.com ukraine

Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

4 years ago fiercebiotech.com covid

Know Labs unveils glucose monitor that swaps fingersticks for RF sensors

4 years ago fiercebiotech.com

Excision's CRISPR HIV therapy is heading into human testing after FDA clearance

4 years ago fiercebiotech.com

BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma

4 years ago fiercebiotech.com cancer mrna

Northwestern U's novel gene-silencing RNA drug shows promise in glioblastoma - Medicine made with real gold nanoparticle cores which can cross the blood-brain barrier to help deliver siRNA to treat brain cancer.

4 years ago fiercebiotech.com brain cancer

Zebrafish reveal regenerative protein that could inspire new treatments for muscle-wasting diseases and aging

4 years ago fiercebiotech.com

BioNTech CEO applies Covid-19 vaccine's mRNA tech to multiple sclerosis

5 years ago fiercebiotech.com covid mrna vaccine

FDA grants Roche coronavirus test emergency green light within 24 hours

6 years ago fiercebiotech.com coronavirus

Scientists at Hanyang University in Seoul reported that mice lost 20% of their body weight and showed reductions in insulin resistance and inflammation when injected with CRISPR interference that targeted the gene FABP4 which is a significant contributor to obesity.

6 years ago fiercebiotech.com

GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D; pact

7 years ago fiercebiotech.com

Bats can host multiple viruses without ever developing symptoms—even potentially fatal ones like Ebola

7 years ago fiercebiotech.com

Stem cells shed light on possible anti-Alzheimer's compound

8 years ago fiercebiotech.com

Surgery, radiation and chemotherapy just don’t cut it against glioblastoma, with 5-year survival rates as low as 5%

8 years ago fiercebiotech.com

9 of 10 individuals who develop lupus are women

8 years ago fiercebiotech.com

A cancer drug may be useful in treating HIV

8 years ago fiercebiotech.com cancer

Researchers have developed a genetically modified version of the herpes virus that infects cancer cells and expresses cytokines that recruit immune cells

8 years ago fiercebiotech.com cancer

New gene therapy halts progression of a potentially fatal neurodegenerative disease, cerebral adrenoleukodystrophy, in 88% if patients treated

8 years ago fiercebiotech.com disease

Fire ant venom inspires potential psoriasis treatment

8 years ago fiercebiotech.com

Researchers at Duke have created an engineered hybrid of poliovirus and rhinovirus which is capable of selectively killing glioblastoma cells while sparing healthy neurons in mouse and human cell line models.

8 years ago fiercebiotech.com

Platypus venom could give rise to a new class of diabetes treatments

9 years ago fiercebiotech.com diabetes

Sean Parker just got federal backing to run the world’s first-ever CRISPR/Cas9 trial, which could alter the way many diseases, especially cancer, are treated.

9 years ago fiercebiotech.com cancer trial

A biotech war is brewing over control of the revolutionary CRISPR-Cas9 tech

11 years ago fiercebiotech.com

More →